Skip to content
drillr.ai
Sign up

NRXP

NRx Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.46
+0.73%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue3.4M1.2M———
Cost of Revenue2.3M505.0K5.0K5.0K4.0K
Gross Profit1.1M720.0K(5.0K)(5.0K)(4.0K)
Operating Expenses
R&D Expense5.4M3.8M6.2M13.4M17.0M
SG&A Expense15.8M13.1M13.5M14.2M27.3M
General & Admin Expense4.7M13.1M———
Selling & Marketing Expense—————
Other Expenses(98.0K)106.0K———
Total Operating Expenses21.1M16.9M19.7M27.6M44.3M
Cost and Expenses23.4M17.4M19.7M27.6M44.3M
Operating Income (EBIT)(20.0M)(16.2M)(19.7M)(27.6M)(44.3M)
Non-Operating
Interest Income17.0K12.0K44.0K494.0K249.0K
Interest Expense1.1M671.0K1.1M120.0K—
Net Interest Income(1.1M)(659.0K)(1.0M)374.0K249.0K
Other Non-Op Income/Expense(3.5M)(12.4M)(5.4M)(2.6M)4.6M
Non-Operating Income (excl Interest)2.4M11.7M4.3M2.4M(4.6M)
EBT (Pre-Tax Income)(23.5M)(28.6M)(25.1M)(30.1M)(39.8M)
Income Tax Expense—————
Bottom Line
Net Income(23.5M)(28.6M)(25.1M)(30.1M)(39.8M)
Earnings from Cont. Ops(23.5M)(28.6M)(25.1M)(30.1M)(39.8M)
Earnings from Discont. Ops—————
Bottom Line Net Income(23.5M)(28.6M)(25.1M)(30.2M)(39.8M)
Per Share
Basic EPS($0.74)($1.34)($2.39)($3.98)($0.60)
Diluted EPS($0.74)($1.34)($2.39)($3.98)($0.60)
Revenue Per Share$0.09$0.06$0.00$0.00$0.00
Shares
Basic Shares Outstanding37.6M21.4M10.5M7.6M65.8M
Diluted Shares Outstanding37.6M21.4M10.5M7.6M65.8M
Profitability Metrics
EBITDA(22.0M)(27.8M)(24.0M)(30.0M)(39.8M)
D&A372.0K143.0K5.0K5.0K4.0K
EBIT(22.3M)(28.0M)(24.0M)(30.0M)(39.8M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026